CytomX Therapeutics, Inc. (CTMX)

SEC filing

CytomX Therapeutics, Inc.

CTMX · CIK 1501989

4/A · Oct 16, 2026 · Director, CEO McCarthy Sean A. sold 101.79K shares at $4.54/share ($461.9K); exercised options for 203.59K shares

4/A

Director, CEO McCarthy Sean A. sold 101.79K shares at $4.54/share ($461.9K); exercised options for 203.59K shares

FORM 4/A

xslF345X06/form4a.xmlSEC.gov

Graphics and non-inline formats (not embedded below).